Head-To-Head Contrast: Bausch + Lomb (NYSE:BLCO) & CarePayment Technologies (OTCMKTS:CPYT)

Bausch + Lomb (NYSE:BLCO) and CarePayment Technologies (OTCMKTS:CPYT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Institutional & Insider Ownership

11.1% of Bausch + Lomb shares are held by institutional investors. 0.2% of Bausch + Lomb shares are held by company insiders. Comparatively, 13.9% of CarePayment Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and price targets for Bausch + Lomb and CarePayment Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bausch + Lomb	2	9	4	0	2.13
CarePayment Technologies	0	0	0	0	0.00

Bausch + Lomb currently has a consensus target price of $16.58, indicating a potential upside of 0.86%. Given Bausch + Lomb’s stronger consensus rating and higher probable upside, research analysts plainly believe Bausch + Lomb is more favorable than CarePayment Technologies.

Earnings and Valuation

This table compares Bausch + Lomb and CarePayment Technologies”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bausch + Lomb	$4.79 billion	1.22	-$317.00 million	($0.87)	-18.90
CarePayment Technologies	N/A	N/A	N/A	N/A	N/A

CarePayment Technologies has lower revenue, but higher earnings than Bausch + Lomb.

Profitability

This table compares Bausch + Lomb and CarePayment Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bausch + Lomb	-6.13%	2.42%	1.15%
CarePayment Technologies	N/A	N/A	N/A

Summary

Bausch + Lomb beats CarePayment Technologies on 7 of the 9 factors compared between the two stocks.

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

About CarePayment Technologies

CarePayment Technologies, Inc. provides accounts receivable services in the United States. It offers services for accounts receivables generated by healthcare providers in connection with providing healthcare services to their patients under the CarePayment brand name. The company was formerly known as microHelix, Inc. CarePayment Technologies, Inc. was founded in 1991 and is based in Lake Oswego, Oregon.